The increase in NOx concentration and the increase in the expression of eNOS mRNA in the use of furostanol glycosides from DM-05 indicate an effective correction of metabolic disorders of nitric oxide after ovariectomy. This evidence concerns the gene NOS3 and metabolic disease.